Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge

Authors: Hong Jin, Chengchun Tang, Qin Wei, Long Chen, Qin Sun, Genshan Ma, Naifeng Liu

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

Few studies have evaluated age-related predictors associated with the underuse of medications in patients with coronary heart disease (CHD). The objective of this study was to identify age-related differences in the factors associated with the underuse of recommended medications in patients diagnosed with acute coronary syndrome (ACS).

Methods

From August 2009 to April 2011, we recruited 469 consecutive ACS patients from a cardiac center at a university hospital. We divided the patients into older (65 years of age and older, n = 202) and younger groups (younger than 65 years of age, n = 267). Data on socio-demographic characteristics, depressive symptoms, and medication use were obtained from a telephone survey administered 18 to 24 months after hospital discharge. Additionally, we asked the patients to provide reasons for not taking their medications.

Results

A significantly increased underuse of medication was noted in older patients compared with younger patients, including aspirin (24.8% vs. 37.1%, p = 0.005), beta-blockers (20.3% vs. 34.8%, p = 0.001), ACE inhibitor/angiotensin receptor blockers (27.2% vs. 36.7%, p = 0.030), and statins (21.8% vs. 29.6%, p = 0.005). Among older patients, the factors associated with the underuse of medications included low education level (odds ratio [OR], 3.93), greater number of comorbidities (OR, 1.64), and total number of discharge medications (OR, 1.31). The reasons provided by older patients for not taking medication included the fact that the medication was considered to be non-essential and the large number of medications. Among younger patients, low income (OR, 3.97) and depression (OR, 2.62) were predictors for underuse of medication, and the reasons provided for not taking medications included high costs and the fear of adverse effects.

Conclusions

At least one year after ACS hospital discharge, the underuse of recommended medications is related to low education level, comorbidities, and the total number of discharge medications in elderly patients, whereas underuse in younger patients is associated with low income and depression. The disparities related to these different predictors may have implications for age-related interventions targeting secondary preventions in CHD patients to improve their use of medication.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang XH, Lu ZL, Liu L: Coronary heart disease in China. Heart. 2008, 94 (9): 1126-1131. 10.1136/hrt.2007.132423.CrossRefPubMed Zhang XH, Lu ZL, Liu L: Coronary heart disease in China. Heart. 2008, 94 (9): 1126-1131. 10.1136/hrt.2007.132423.CrossRefPubMed
2.
go back to reference Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110 (10): 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110 (10): 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed
3.
go back to reference Niu S, Zhao D, Zhu J, Liu J, Liu Q, Liu J, Wang W, Smith SC: The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J. 2009, 157 (4): 709-715. 10.1016/j.ahj.2008.12.009. e1CrossRefPubMed Niu S, Zhao D, Zhu J, Liu J, Liu Q, Liu J, Wang W, Smith SC: The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J. 2009, 157 (4): 709-715. 10.1016/j.ahj.2008.12.009. e1CrossRefPubMed
4.
go back to reference Yang Z, Olomu A, Corser W, Rovner DR, Holmes-Rovner M: Outpatient medication use and health outcomes in post-acute coronary syndrome patients. Am J Manag Care. 2006, 12 (10): 581-587.PubMed Yang Z, Olomu A, Corser W, Rovner DR, Holmes-Rovner M: Outpatient medication use and health outcomes in post-acute coronary syndrome patients. Am J Manag Care. 2006, 12 (10): 581-587.PubMed
5.
go back to reference Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC: Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008, 51 (13): 1247-1254. 10.1016/j.jacc.2007.10.063.CrossRefPubMed Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC: Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008, 51 (13): 1247-1254. 10.1016/j.jacc.2007.10.063.CrossRefPubMed
6.
go back to reference Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006, 47 (10): 2130-2139. 10.1016/j.jacc.2006.04.026.CrossRefPubMed Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006, 47 (10): 2130-2139. 10.1016/j.jacc.2006.04.026.CrossRefPubMed
7.
go back to reference DeWilde S, Carey IM, Richards N, Whincup PH, Cook DG: Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart. 2008, 94 (1): 83-88. 10.1136/hrt.2006.111757.CrossRefPubMed DeWilde S, Carey IM, Richards N, Whincup PH, Cook DG: Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart. 2008, 94 (1): 83-88. 10.1136/hrt.2006.111757.CrossRefPubMed
8.
go back to reference Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006, 113 (19): 2363-2372. 10.1161/CIRCULATIONAHA.106.174516.CrossRefPubMed Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006, 113 (19): 2363-2372. 10.1161/CIRCULATIONAHA.106.174516.CrossRefPubMed
9.
go back to reference Ho PM, Bryson CL, Rumsfeld JS: Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009, 119 (23): 3028-3035. 10.1161/CIRCULATIONAHA.108.768986.CrossRefPubMed Ho PM, Bryson CL, Rumsfeld JS: Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009, 119 (23): 3028-3035. 10.1161/CIRCULATIONAHA.108.768986.CrossRefPubMed
10.
go back to reference Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK: 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011, 123 (18): 2022-2060.CrossRefPubMed Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK: 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011, 123 (18): 2022-2060.CrossRefPubMed
11.
go back to reference Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009, 120 (22): 2271-2306. 10.1161/CIRCULATIONAHA.109.192663.CrossRefPubMed Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009, 120 (22): 2271-2306. 10.1161/CIRCULATIONAHA.109.192663.CrossRefPubMed
12.
go back to reference Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006, 166 (17): 1842-1847. 10.1001/archinte.166.17.1842.CrossRefPubMed Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006, 166 (17): 1842-1847. 10.1001/archinte.166.17.1842.CrossRefPubMed
13.
go back to reference Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM: Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006, 113 (2): 203-212. 10.1161/CIRCULATIONAHA.105.505636.CrossRefPubMed Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM: Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006, 113 (2): 203-212. 10.1161/CIRCULATIONAHA.105.505636.CrossRefPubMed
14.
go back to reference Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS: Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008, 155 (4): 772-779. 10.1016/j.ahj.2007.12.011.CrossRefPubMed Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS: Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008, 155 (4): 772-779. 10.1016/j.ahj.2007.12.011.CrossRefPubMed
15.
go back to reference Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, Rasmussen S, Kober L, Stender S, Madsen M, Torp-Pedersen C: Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006, 27 (10): 1153-1158.CrossRefPubMed Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, Rasmussen S, Kober L, Stender S, Madsen M, Torp-Pedersen C: Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006, 27 (10): 1153-1158.CrossRefPubMed
16.
go back to reference Ali RC, Melloni C, Ou FS, Schmader K, Ohman EM, Roe MT, Peterson ED, Alexander KP: Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time. J Am Geriatr Soc. 2009, 57 (11): 1990-1996. 10.1111/j.1532-5415.2009.02483.x.CrossRefPubMed Ali RC, Melloni C, Ou FS, Schmader K, Ohman EM, Roe MT, Peterson ED, Alexander KP: Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time. J Am Geriatr Soc. 2009, 57 (11): 1990-1996. 10.1111/j.1532-5415.2009.02483.x.CrossRefPubMed
17.
go back to reference Lee HY, Cooke CE, Robertson TA: Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008, 14 (3): 271-280.PubMed Lee HY, Cooke CE, Robertson TA: Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008, 14 (3): 271-280.PubMed
18.
go back to reference Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED: Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006, 151 (1): 185-191. 10.1016/j.ahj.2005.02.038.CrossRefPubMed Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED: Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006, 151 (1): 185-191. 10.1016/j.ahj.2005.02.038.CrossRefPubMed
19.
go back to reference Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999, 282 (18): 1737-1744. 10.1001/jama.282.18.1737.CrossRefPubMed Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999, 282 (18): 1737-1744. 10.1001/jama.282.18.1737.CrossRefPubMed
20.
go back to reference Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F: Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009, 157 (3): 509-516. 10.1016/j.ahj.2008.09.026. e1CrossRefPubMed Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F: Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009, 157 (3): 509-516. 10.1016/j.ahj.2008.09.026. e1CrossRefPubMed
21.
go back to reference Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O’Gara P, Whitlow P: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007, 115 (6): 813-818. 10.1161/CIRCULATIONAHA.106.180944.CrossRefPubMed Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O’Gara P, Whitlow P: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007, 115 (6): 813-818. 10.1161/CIRCULATIONAHA.106.180944.CrossRefPubMed
22.
go back to reference Makaryus AN, Friedman EA: Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005, 80 (8): 991-994. 10.4065/80.8.991.CrossRefPubMed Makaryus AN, Friedman EA: Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005, 80 (8): 991-994. 10.4065/80.8.991.CrossRefPubMed
23.
go back to reference Kripalani S, Henderson LE, Jacobson TA, Vaccarino V: Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008, 83 (5): 529-535. 10.1016/S0025-6196(11)60724-6.CrossRefPubMed Kripalani S, Henderson LE, Jacobson TA, Vaccarino V: Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008, 83 (5): 529-535. 10.1016/S0025-6196(11)60724-6.CrossRefPubMed
25.
go back to reference Garner JB: Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010, 105 (10): 1495-1501. 10.1016/j.amjcard.2009.12.077.CrossRefPubMed Garner JB: Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010, 105 (10): 1495-1501. 10.1016/j.amjcard.2009.12.077.CrossRefPubMed
26.
go back to reference Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD: Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013, 35 (4): 385-398. 10.1016/j.clinthera.2013.02.019. e1CrossRefPubMed Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD: Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013, 35 (4): 385-398. 10.1016/j.clinthera.2013.02.019. e1CrossRefPubMed
27.
go back to reference Mojtabai R, Olfson M: Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003, 22 (4): 220-229. 10.1377/hlthaff.22.4.220.CrossRef Mojtabai R, Olfson M: Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003, 22 (4): 220-229. 10.1377/hlthaff.22.4.220.CrossRef
28.
go back to reference Xu L, Wang Y, Collins CD, Tang S: Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv Res. 2007, 7: 37-10.1186/1472-6963-7-37.CrossRefPubMedPubMedCentral Xu L, Wang Y, Collins CD, Tang S: Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv Res. 2007, 7: 37-10.1186/1472-6963-7-37.CrossRefPubMedPubMedCentral
29.
go back to reference Fang K, Jiang Y, Shia B, Ma S: Impact of illness and medical expenditure on household consumptions: a survey in western China. PLoS One. 2012, 7 (12): e52928-10.1371/journal.pone.0052928.CrossRefPubMedPubMedCentral Fang K, Jiang Y, Shia B, Ma S: Impact of illness and medical expenditure on household consumptions: a survey in western China. PLoS One. 2012, 7 (12): e52928-10.1371/journal.pone.0052928.CrossRefPubMedPubMedCentral
30.
go back to reference Jiang W, Glassman A, Krishnan R, O’Connor CM, Califf RM: Depression and ischemic heart disease: what have we learned so far and what must we do in the future?. Am Heart J. 2005, 150 (1): 54-78. 10.1016/j.ahj.2005.04.012.CrossRefPubMed Jiang W, Glassman A, Krishnan R, O’Connor CM, Califf RM: Depression and ischemic heart disease: what have we learned so far and what must we do in the future?. Am Heart J. 2005, 150 (1): 54-78. 10.1016/j.ahj.2005.04.012.CrossRefPubMed
32.
go back to reference Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005, 165 (21): 2508-2513. 10.1001/archinte.165.21.2508.CrossRefPubMedPubMedCentral Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005, 165 (21): 2508-2513. 10.1001/archinte.165.21.2508.CrossRefPubMedPubMedCentral
33.
go back to reference Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, Vorchheimer D, Davidson KW: Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J. 2006, 152 (5): 922-927. 10.1016/j.ahj.2006.05.014.CrossRefPubMed Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, Vorchheimer D, Davidson KW: Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J. 2006, 152 (5): 922-927. 10.1016/j.ahj.2006.05.014.CrossRefPubMed
34.
go back to reference Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC: Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012, 109 (9): 1266-1271. 10.1016/j.amjcard.2011.12.017.CrossRefPubMed Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC: Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012, 109 (9): 1266-1271. 10.1016/j.amjcard.2011.12.017.CrossRefPubMed
35.
go back to reference Ali R, Alexander KP: Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Am J Geriatr Pharmacother. 2007, 5 (1): 52-63. 10.1016/j.amjopharm.2007.03.008.CrossRefPubMed Ali R, Alexander KP: Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Am J Geriatr Pharmacother. 2007, 5 (1): 52-63. 10.1016/j.amjopharm.2007.03.008.CrossRefPubMed
36.
go back to reference McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, Steiner JF: Factors related to adherence to statin therapy. Ann Pharmacother. 2007, 41 (11): 1805-1811. 10.1345/aph.1K209.CrossRefPubMed McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, Steiner JF: Factors related to adherence to statin therapy. Ann Pharmacother. 2007, 41 (11): 1805-1811. 10.1345/aph.1K209.CrossRefPubMed
37.
go back to reference Cook SC, Arnott LM, Nicholson LM, Cook LR, Sparks EA, Daniels CJ: Erectile dysfunction in men with congenital heart disease. Am J Cardiol. 2008, 102 (12): 1728-1730. 10.1016/j.amjcard.2008.08.017.CrossRefPubMed Cook SC, Arnott LM, Nicholson LM, Cook LR, Sparks EA, Daniels CJ: Erectile dysfunction in men with congenital heart disease. Am J Cardiol. 2008, 102 (12): 1728-1730. 10.1016/j.amjcard.2008.08.017.CrossRefPubMed
38.
go back to reference Diaz A, Tardif JC: Heart rate slowing versus other pharmacological antianginal strategies. Adv Cardiol. 2006, 43: 65-78.CrossRefPubMed Diaz A, Tardif JC: Heart rate slowing versus other pharmacological antianginal strategies. Adv Cardiol. 2006, 43: 65-78.CrossRefPubMed
39.
go back to reference Gehi AK, Ali S, Na B, Whooley MA: Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007, 167 (16): 1798-1803. 10.1001/archinte.167.16.1798.CrossRefPubMedPubMedCentral Gehi AK, Ali S, Na B, Whooley MA: Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007, 167 (16): 1798-1803. 10.1001/archinte.167.16.1798.CrossRefPubMedPubMedCentral
40.
go back to reference Rashid MA, Edwards D, Walter FM, Mant J: Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med. 2014, 12 (3): 224-232. 10.1370/afm.1620.CrossRefPubMedPubMedCentral Rashid MA, Edwards D, Walter FM, Mant J: Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med. 2014, 12 (3): 224-232. 10.1370/afm.1620.CrossRefPubMedPubMedCentral
41.
go back to reference Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG: Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004, 117 (2): 73-81. 10.1016/j.amjmed.2003.12.041.CrossRefPubMed Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG: Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004, 117 (2): 73-81. 10.1016/j.amjmed.2003.12.041.CrossRefPubMed
42.
go back to reference Lappe JM, Muhlestein JB, Lappe DL, Badger RS, Bair TL, Brockman R, French TK, Hofmann LC, Horne BD, Kralick-Goldberg S, Nicponski N, Orton JA, Pearson RR, Renlund DG, Rimmasch H, Roberts C, Anderson JL: Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med. 2004, 141 (6): 446-453. 10.7326/0003-4819-141-6-200409210-00010.CrossRefPubMed Lappe JM, Muhlestein JB, Lappe DL, Badger RS, Bair TL, Brockman R, French TK, Hofmann LC, Horne BD, Kralick-Goldberg S, Nicponski N, Orton JA, Pearson RR, Renlund DG, Rimmasch H, Roberts C, Anderson JL: Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med. 2004, 141 (6): 446-453. 10.7326/0003-4819-141-6-200409210-00010.CrossRefPubMed
Metadata
Title
Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge
Authors
Hong Jin
Chengchun Tang
Qin Wei
Long Chen
Qin Sun
Genshan Ma
Naifeng Liu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-127

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue